Manufacturers Life Insurance Company, The Avidity Biosciences, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 257,456 shares of RNA stock, worth $12.9 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
257,456
Previous 272,762
5.61%
Holding current value
$12.9 Million
Previous $11.1 Million
6.12%
% of portfolio
0.01%
Previous 0.01%
Shares
21 transactions
Others Institutions Holding RNA
# of Institutions
255Shares Held
107MCall Options Held
224KPut Options Held
161K-
Price T Rowe Associates Inc Baltimore, MD10.6MShares$531 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.23MShares$461 Million0.01% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$431 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY8.13MShares$406 Million5.95% of portfolio
-
Wellington Management Group LLP Boston, MA7.03MShares$351 Million0.06% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $2.6B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...